how can her2-targeted therapies be incorporated into the management of patients with crc?
Published 1 year ago • 55 plays • Length 47:29Download video MP4
Download video MP3
Similar videos
-
36:45
decoding her2 in nsclc: advances in biomarker testing and targeted therapies
-
34:27
fulfilling the potential of her2-targeting in colorectal cancer: update on detection and management
-
33:28
novel targeted therapies for nsclc: exploring her2 dysregulation
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
35:36
personalized treatment of advanced her2-negative gastric or gastroesophageal junction cancer
-
17:50
her2陽性乳がんと向き合って 森 久美子
-
5:37
how to treat her2-positive (her2 ) breast cancer: all you need to know
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
34:21
expanding options for her2 advanced breast cancer: taking trial data to the clinic
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
1:43
phase i study of anti-her2 car-engineered monocytes in her2-overexpressing solid tumors
-
15:09
expanding the reach of her2 in solid tumours: a spotlight on tumour-agnostic approaches
-
1:07
targeting her2 in colorectal cancer
-
0:59
sequencing her2-targeted therapies in breast cancer
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer
-
2:50
targeted therapy and her2-positive breast cancer | health explainers | sharecare
-
4:52
3-year dfs in randomized trials of chemotherapy and her2-targeted therapy
-
1:43
dr. tripathy discusses her2 targeted therapies
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
5:55
decision-making in metastatic her2 breast cancer
-
3:12
advances in her2-targeted therapies for gastric cancer